Pro Medicus Limited
PMCUF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$20.5B
Close$
$31.21
76.4% downside
Current Fair Value
76.4% downsideOvervalued by 76.4% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $20.50 Billion |
|---|---|
| Enterprise Value | - |
| Annual dividend | $0.49 |
| Dividend yield | 0.35% |
| Earnings per Share | $2.54 |
| Beta | 0.57 |
| Outstanding Shares | 104,469,963 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 77.24 |
|---|---|
| PEG | 159.97 |
| Price to Sales | 33.04 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Last Earnings Call
Report Date
August 17, 2026
EPS Estimate
$0.48
Consensus analyst estimateRevenue Estimate
$94.10 M
Consensus analyst estimateNext Earnings Call
Expected Date
February 16, 2027
EPS Estimate
$0.59
Consensus analyst estimateRevenue Estimate
$113.68 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Pro Medicus Limited
153 employees
CEO: Sam Aaron Hupert
Based in Richmond, Australia, and established in 1983, Pro Medicus Limited is a leading developer and provider of cutting-edge healthcare imaging software and support services. The company caters to a diverse range of medical institution...